Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Diet modifications, exercise, and weight loss (if appropriate) are recommended for patients with dyslipidemia
  • Other cardiovascular disease–associated risk factors should be addressed where present, eg, tobacco use, diabetes, and untreated renal disease
  • Pharmacologic interventions are recommended where dyslipidemia is unresponsive to lifestyle changes

Action required